Does BELANTAMAB MAFODOTIN Cause Diplopia? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Diplopia have been filed in association with BELANTAMAB MAFODOTIN (Blenrep). This represents 2.6% of all adverse event reports for BELANTAMAB MAFODOTIN.
60
Reports of Diplopia with BELANTAMAB MAFODOTIN
2.6%
of all BELANTAMAB MAFODOTIN reports
10
Deaths
12
Hospitalizations
How Dangerous Is Diplopia From BELANTAMAB MAFODOTIN?
Of the 60 reports, 10 (16.7%) resulted in death, 12 (20.0%) required hospitalization, and 9 (15.0%) were considered life-threatening.
Is Diplopia Listed in the Official Label?
Yes, Diplopia is listed as a known adverse reaction in the official FDA drug label for BELANTAMAB MAFODOTIN.
What Other Side Effects Does BELANTAMAB MAFODOTIN Cause?
Keratopathy (788)
Visual acuity reduced (708)
Death (499)
Plasma cell myeloma (380)
Dry eye (359)
Night blindness (317)
Photophobia (183)
Foreign body sensation in eyes (151)
Vision blurred (134)
Ocular toxicity (94)
What Other Drugs Cause Diplopia?
ESOMEPRAZOLE (585)
SIMVASTATIN (560)
PREGABALIN (556)
HYDROCHLOROTHIAZIDE (544)
BISOPROLOL (541)
ADALIMUMAB (531)
FINGOLIMOD (505)
LEVOTHYROXINE (473)
APIXABAN (471)
ATORVASTATIN (396)
Which BELANTAMAB MAFODOTIN Alternatives Have Lower Diplopia Risk?
BELANTAMAB MAFODOTIN vs BELANTAMAB MAFODOTIN-BLMF
BELANTAMAB MAFODOTIN vs BELATACEPT
BELANTAMAB MAFODOTIN vs BELIMUMAB
BELANTAMAB MAFODOTIN vs BELINOSTAT
BELANTAMAB MAFODOTIN vs BELUMOSUDIL